More than 20 states have passed so-called "Right-to-Try" laws that give terminally ill patients access to experimental drugs. What bypassing the F.D.A. could mean for clinical trials, treatment outcomes and patient safety.
From the herbal engergy drinks of ancient Olympians to today’s performance enhancing drugs, humans have searched for ways to make their bodies better. A professor of bioethics talks about the pitfalls and benefits to individuals and society when people pursue physical excellence.
- Max Mehlman professor of law and bioethics at Case Western Reserve University and the author of "Wondergenes"; "The Encyclopedia of Ethical, Legal, and Policy Issues in Biotechnology"; and "Access to the Genome."
Most Recent Shows
World leaders meet for the UN climate change summit in Paris to discuss plans for reducing carbon emissions. What's at stake for the talks, and prospects for a major agreement.
A molecular-biologist-turned-Buddhist-monk says altruism is the answer to many of the world's most pressing challenges. Can concern for others help solve wealth inequality, climate change and world hunger?
Kate Mulgrew, who stars as "Red" in the Netflix TV series "Orange Is The New Black", opens up in a new memoir about her complicated family and the baby she gave away for adoption as a young woman.